Abstract

Gas partial pressures within the cell microenvironment are one of the key modulators of cell pathophysiology. Indeed, respiratory gases (O2 and CO2) are usually altered in respiratory diseases and gasotransmitters (CO, NO, H2S) have been proposed as potential therapeutic agents. Investigating the pathophysiology of respiratory diseases in vitro mandates that cultured cells are subjected to gas partial pressures similar to those experienced by each cell type in its native microenvironment. For instance, O2 partial pressures range from ∼13% in the arterial endothelium to values as low as 2–5% in cells of other healthy tissues and to less than 1% in solid tumor cells, clearly much lower values than those used in conventional cell culture research settings (∼19%). Moreover, actual cell O2 partial pressure in vivo changes with time, at considerably different timescales as illustrated by tumors, sleep apnea, or mechanical ventilation. Unfortunately, the conventional approach to modify gas concentrations at the above culture medium precludes the tight and exact control of intra-cellular gas levels to realistically mimic the natural cell microenvironment. Interestingly, well-controlled cellular application of gas partial pressures is currently possible through commercially available silicone-like material (PDMS) membranes, which are biocompatible and have a high permeability to gases. Cells are seeded on one side of the membrane and tailored gas concentrations are circulated on the other side of the membrane. Using thin membranes (50–100 μm) the value of gas concentration is instantaneously (<0.5 s) transmitted to the cell microenvironment. As PDMS is transparent, cells can be concurrently observed by conventional or advanced microscopy. This procedure can be implemented in specific-purpose microfluidic devices and in settings that do not require expensive or complex technologies, thus making the procedure readily implementable in any cell biology laboratory. This review describes the gas composition requirements for a cell culture in respiratory research, the limitations of current experimental settings, and also suggests new approaches to better control gas partial pressures in a cell culture.

Highlights

  • Specialty section: This article was submitted to Respiratory Physiology, a section of the journal Frontiers in Physiology

  • Investigating the pathophysiology of respiratory diseases in vitro mandates that cultured cells are subjected to gas partial pressures similar to those experienced by each cell type in its native microenvironment

  • O2 partial pressures range from ∼13% in the arterial endothelium to values as low as 2–5% in cells of other healthy tissues and to less than 1% in solid tumor cells, clearly much lower values than those used in conventional cell culture research settings (∼19%)

Read more

Summary

LIMITATIONS

The most simple and straightforward method to subject cultured cells to a given gas concentration consists of setting the partial pressure of the gas on top of the culture media to the desired value. A further development of the concept of circulating gas-preconditioned media on the cells consisted of a setting based on exposing cells to a medium that is bubbled with the appropriate mixture of gases into two separate containers and directed to the cells being cultured in standard glass coverslips with the aid of bidirectional peristaltic pumps (Tsapikouni et al, 2012) This experimental setting allowed actual application of intermittent hypoxia/hyperoxia–normoxia at rates corresponding to severe sleep apnea (60 cycles/h) (Figure 3) with the advantage that the cell culture is readily available for inspection with any microscopy technique or bio-analytical assay. Having such wells a conventional culture area allows cells under controlled gas conditions to be subjected to all biological and molecular common tests, including those involving real-time microscopic cell inspection. It is expected that in addition to those devices already commercially available (Kieninger et al, 2018a), a large variety of commercial cell culture systems will soon become readily available which will hopefully drive their cost down

CONCLUSION
Findings
ETHICS STATEMENT

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.